Spotlight on Margaret Rogers – MND Clinic support nurse
Character and clinical leadership are two attributes of the well revered Clinical Nurse Consultant (CNC) (retired) and avid West Coast...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
The Motor Neurone Disease Genetics and Therapeutics Research Group, led by Professor Anthony Akkari, aims to identify genetic mechanisms and mutations in neurological conditions, particularly motor neurone diseases. Our focus is to translate this research into developing personalised treatments. We work closely with Professors Steve Wilton and Sue Fletcher towards this goal.
Through Professor Akkari’s background in pharmacogenetics, Perron Institute’s MND research approach is distinct and unique to other efforts around the world. Our team have successfully created a comprehensive pipeline of targeted therapeutics for MND, we expect shortly we will have phase one ready targeted MND therapy for a small group of patients with SOD1 mutations and sporadic ALS.
MND Clinics provide reviews to anticipate and solve problems that occur as a result of the progressive neurological disorder.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.